{"id":232354,"date":"2021-04-21T18:00:08","date_gmt":"2021-04-21T15:00:08","guid":{"rendered":"https:\/\/en.buradabiliyorum.com\/peter-thiel-backed-psychedelic-drug-maker-aims-to-raise-100m-in-ipo\/"},"modified":"2021-04-21T18:00:08","modified_gmt":"2021-04-21T15:00:08","slug":"peter-thiel-backed-psychedelic-drug-maker-aims-to-raise-100m-in-ipo","status":"publish","type":"post","link":"https:\/\/buradabiliyorum.com\/en\/peter-thiel-backed-psychedelic-drug-maker-aims-to-raise-100m-in-ipo\/","title":{"rendered":"#Peter Thiel-backed psychedelic drug maker aims to raise $100M in IPO"},"content":{"rendered":"

“#Peter Thiel-backed psychedelic drug maker aims to raise $100M in IPO<\/strong>”<\/p>\n

\n

Psychedelic drugmaker ATAI Life Science<\/a>, which backed by billionaire investor Peter Thiel, said it is planning to raise $100 million in an initial public offering. <\/p>\n

The Berlin-based company \u2014 which tests drugs like ketamine, DMT and psilocybin, the active ingredient in \u201cmagic mushrooms,\u201d to treat depression \u2014 raised an aggregate of $362.3 million from private investors so far, according to its S-1 filing to the Securities and Exchange Commission submitted late Tuesday.<\/p>\n

The company said it is planning to sell its shares on the NASDAQ under the symbol ATAI. An IPO date has not been set. <\/p>\n

Aside from depression, ATAI is also developing psychedelics and other drugs to treat anxiety, opioid addiction, post traumatic stress disorder and cognitive impairment associated with schizophrenia, among things, according to the company website. <\/p>\n

ATAI, which has roughly 50 staff in offices in Berlin, New York and San Diego, is partnered with 14 companies focusing on drug development and other technologies. ATAI helps the scientists raise money, work with regulators and conduct clinical trials in exchange for a majority stake in the drugs and tech they are developing. So far, none of the company\u2019s drugs have been formally app<\/a>roved by regulators, however. <\/p>\n

\"Mazatec
Mazatec psilocybin mushrooms harvested from their growing tubs May 19, 2019 in Denver, Colorado. <\/figcaption>
Denver Post via Getty Images<\/span><\/figcaption><\/figure>\n

Thiel, a PayPal co-founder and early Facebook<\/a> investor, who prominently supported President Trump\u2019s 2016 campaign and funded the downfall of snarky blog, Gawker, made a $12 million investment in ATAI through his venture capital firm, Thiel Capital, in November. <\/p>\n

\u201cATAI\u2019s great virtue is to take mental illness as seriously as we should have been taking all illness all along,\u201d Thiel told CNBC at the time. \u201cThe company\u2019s most valuable asset is its sense of urgency.\u201d<\/p>\n

Founded in 2018 by entrepreneurs Christian Angermayer, Florian Brand, Lars Wilde and Srinivas Rao, ATAI has invested in Compass Pathways, which has developed a synthetic version of psilocybin. <\/p>\n

Compass Pathways, which Thiel has also invested in, listed on NASDAQ in September and now has a valuation of around $1.3 billion.\n <\/p><\/div>\n

If you liked the article, do not forget to share it with your friends. Follow us on\u00a0Google News<\/a><\/span>\u00a0too, click on the star and choose us from your favorites.<\/span><\/strong><\/p><\/blockquote>\n

\n

For forums sites go to Forum.BuradaBiliyorum.Com<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n

\n

If you want to read more News<\/a> articles, you can visit our News category.<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n

Source<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

“#Peter Thiel-backed psychedelic drug maker aims to raise $100M in IPO” Psychedelic drugmaker ATAI Life Science, which backed by billionaire investor Peter Thiel, said it is planning to raise $100 million in an initial public offering. The Berlin-based company \u2014 which tests drugs like ketamine, DMT and psilocybin, the active ingredient in \u201cmagic mushrooms,\u201d to…<\/p>\n","protected":false},"author":1,"featured_media":232355,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/nypost.com\/wp-content\/uploads\/sites\/2\/2021\/04\/peter-thiel-psychedelics.jpg?quality=90&strip=all&w=1200","fifu_image_alt":"","footnotes":""},"categories":[70897],"tags":[102877,71059,73745,6864,70989,78765,73799],"class_list":["post-232354","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-4-21-21","tag-addiction","tag-depression","tag-drugs","tag-mental-health","tag-mushrooms","tag-peter-thiel"],"_links":{"self":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/232354","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/comments?post=232354"}],"version-history":[{"count":0,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/232354\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media\/232355"}],"wp:attachment":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media?parent=232354"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/categories?post=232354"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/tags?post=232354"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}